ArticleProceedings of the National Academy of Sciences of the United States of America2021

Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders.

Hong Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.